New BMW CE 04 Teased Ahead Of Launch; Check Details
BMW Motorrad is going to launch an updated version of the CE 04 in the global market. Before the event, the Bavarian giant released a teaser on the social media platform. Although the teaser doesn't reveal much, it does hint at a change of aesthetics for the model. Based on the announcement, this version of the two-wheeler will make its debut on July 5. It comes as part of the brand's strategy of launching multiple new products, which until now included various models based on the 1300 cc platform.
The BMW CE 04 was initially launched in 2022 and is currently in its third model year in the international market. The teaser released by the automaker shows a side panel of the model featuring its badge. Looking at this part, it is hard to judge if the brand is going to change the design or just introduce a new paint scheme. In the teaser, the brand has hinted at a matter-blue colour with fluorescent accents.
The BMW CE 04 currently features an 8.5 kWh battery, which provides a claimed range of 130 km. It is equipped with a liquid-cooled permanent magnet motor, a feature that is quite uncommon in India, producing a peak power output of 31 kW and 62 Nm of torque. Power is transmitted to the rear wheel through a belt final drive.
The updated CE 04 is expected to launch in India shortly after its worldwide debut. It's important to note that, unlike the CE 02, which is produced locally in India by TVS, the CE 04 is imported as a Completely Built Unit (CBU), resulting in higher taxation. Therefore, it is priced at Rs 14.90 lakh (ex-showroom).
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hans India
37 minutes ago
- Hans India
Kolhapuri Chappals: Prada accepts Indian craftsmanship, open for meaningful exchange with artisans
New Delhi: After facing severe backlash, Italian fashion house Prada has officially admitted that the Kolhapuri Chappals, featured in the recent Prada Men's 2026 Fashion Show, is inspired by India's handcrafted footwear traditions. In a letter to Lalit Gandhi, president of Maharashtra Chamber of Commerce, Industry, and Agriculture, Prada noted that it is 'open for meaningful exchange with artisans'. 'We acknowledge that the sandals featured in the recent Prada Men's 2026 Fashion Show are inspired by traditional Indian handcrafted footwear, with a centuries-old heritage. We deeply recognise the cultural significance of such Indian craftsmanship,' said Lorenzo Bertelli, Prada Group Head of Corporate Social Responsibility, in a letter to Gandhi. The luxury fashion house came under fire after showcasing the sandals during its Spring/Summer 2026 menswear show in Milan, priced at more than Rs 1 lakh as against the Rs 300-Rs 1500 sold in Kolhapur's markets. After images of the collection surfaced online, social media users and Indian officials criticised the label for failing to credit the heritage behind the designs. They accused Prada of cultural appropriation and disregard for the traditional artisans who have crafted these leather sandals for generations. Gandhi had in a letter to Prada shared concerns that 'the collection includes footwear designs that bear a close resemblance to Kolhapuri Chappals (Footwear) a traditional handcrafted leather sandal that has been awarded Geographical Indication (GI) status by the Government of India in 2019'. Besides representing the 'centuries-old regional identity of Maharashtra', the Kolhapuri Chappals also support the livelihoods of thousands of artisans and families in the Kolhapur region and surrounding districts, Gandhi wrote. Gandhi called out Prada for commercialising the centuries-old footwear designs 'without due acknowledgment, credit, or collaboration with the artisan communities', and urged them to 'consider supporting ethical fashion practices that respect traditional knowledge and cultural rights'. In his response, Bertelli wrote, 'Please note that, for now, the entire collection is currently at an early stage of design. Development and none of the pieces are confirmed to be produced or commercialised. 'We are committed to responsible design practices, fostering cultural engagement, and opening a dialogue for a meaningful exchange with local Indian artisan communities as we have done in the past in other collections to ensure the rightful recognition of their craft,' he said.
Business Standard
an hour ago
- Business Standard
Hind Rectifiers secures Rs 101 cr supply order from Indian Railways
Hind Rectifiers has announced that it has received a supply order worth Rs 101 crore from Indian Railways. According to an exchange filing, the domestic order will be executed as per the terms and conditions laid out by Indian Railways. The execution is scheduled from FY 202526 to FY 202627. The company also clarified that the transaction does not involve any related parties. Neither the promoter, promoter group, nor any group companies have any financial or other interest in the awarding entity. The official announcement was made on 27 June 2025, after market hours. Hind Rectifiers is engaged in developing, designing, manufacturing, and marketing electronic, electrical, and electromechanical equipment; power electronic equipment; and railway traction equipment. The companys standalone net profit zoomed 98.2% to Rs 10.15 crore on a 22.3% increase in net sales to Rs 185.05 crore in Q4 FY25 compared to Q4 FY24. The scrip rose 2.20% to settle at Rs 1,262.70 on Friday, 27 June 2025.
Business Standard
an hour ago
- Business Standard
Granules India receives one observation from USFDA following inspection at U.S. facility
Granules India announced that its wholly-owned foreign subsidiary, located in Chantilly, Virginia, USA, has received one observation in Form 483 from the United States Food and Drug Administration (USFDA). In a regulatory filing, the company stated that the USFDA conducted a Pre-Approval Inspection (PAI) at the facility from 23 June to 27 June 2025. At the conclusion of the inspection, the USFDA issued a Form 483 with one observation. Granules Pharmaceuticals, Inc. addressed and resolved the observation during the inspection. The official announcement was made on 27 June 2025, after market hours. Granules India is primarily involved in the manufacturing and sale of active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs), and finished dosages (FDs). The companys consolidated net profit rose by 17.3% to Rs 152.03 crore, on a 2.4% increase in total revenue from operations to Rs 1,196.82 crore in Q4 FY25, compared to Q4 FY24. The scrip rose 0.03% to settle at Rs 497.30 on Friday, 27 June 2025.
